ALGN · NASDAQ
Align Technology, Inc.
$152.00 -0.04 (-0.03%)
Company overview
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and related services for orthodontists and general practitioner dentists, as well as restorative and aesthetic dentistry. The company operates through two segments: Clear Aligner and Scanners and Services. The Clear Aligner segment offers comprehensive products including Invisalign treatment for teenage patients, featuring mandibular advancement, compliance indicators, and tooth eruption compensation, as well as Invisalign First Phase I and Phase 2 packages for younger patients ages 7-10 with mixed primary and permanent teeth. Non-comprehensive products include Invisalign Moderate, Lite, and Express packages, along with Invisalign Go.
- Sector
- Healthcare
- Industry
- Medical - Devices
- Exchange
- NASDAQ
- Market cap
- $10.8B
- Employees
- 21,200
- Headquarters
- Tempe, AZ
- Website
- aligntech.com
- CEO
- Joseph Hogan
- Listed
- January 30, 2001
- P/E
- 25.46
- Dividend yield
- 0.00%
Company financials
- Revenue
- $4.1B
- Gross profit
- $2.8B
- Operating income
- $592M
- EBITDA
- $807M
- Net income
- $430M
- EPS
- $5.97
- Total assets
- $6.3B
- Total debt
- $83.4M
- Gross margin
- 67.68%
- Net margin
- 10.50%
- Earnings yield
- 3.93%
Showing FY 2025
ALGN
1D
NASDAQ
O152.03H152.70L150.77C151.95-0.31 (-0.20%)Vol681.78K